These are exciting times at ABS as we continue our progress towards regulatory approval globally and the release of our advanced stenting system worldwide. Within a few short years, most open heart surgeries could become a thing of the past.
Firm Financial Footing
The medical field is a competitive one with innovative research teams competing to attract the attention of major investors. That’s why adding Ken Richards to our team was so important. He brings with him a wealth of experience in the investment arena working for successful investment firms such as York Bridge Capital and CIBC World Markets. Ken has the expertise to help ABS reach its $20 million funding target.
Ken’s a graduate of Dalhousie University in Halifax, Nova Scotia and that’s not the only Canadian connection at ABS. On October 3, 2017, we also made a major announcement about our next wave of human clinical trials in partnership with Dalhousie University’s Medical School in New Brunswick. Planning is well underway to begin this next phase of trials at the medical school. This is a big “next step” in our steady progress towards the eventual commercial role out of our innovative stenting system.
Our breakthrough technology received a lot of positive feedback at the recent European Bifurcation Club meeting in Portugal where our CMO, Dr. Mehran Khorsandi, talked about our new procedure. We’ve been able to use this to continue our momentum and we’re excited about what the next few months has in store.
How it Works
Our new technology is designed to replace less reliable stenting methods used today. Our procedure covers all types of lesions regardless of branch angle, size, plaque burden or location. Our system places stents in both the main branch and side branch simultaneously and its self-aligning to virtually eliminate the need for further surgery.
Once we’ve received full regulatory approval I believe that the Advanced Bifurcation Systems Platform will become the method of choice for most interventionist cardiologists.
Special thanks to the team at CEOCFO Magazine for interviewing me all about what we are doing here at ABS. Advanced Bifurcation Systems believes that new techniques can lead to more coronary stenting and higher success rates and less open heart surgery. It is grat to get the story out and I appreciate the attention and exposure.
People are hungry for good news about health and medicine. Thank you to everyone on Facebook who responded to my post. On the announcement and presentation on October 14th of the ABS platform for stenting bifurcation lesions.
I posted a link to a recent Huffington Post article about how we hope that our system will allow more interventionist cardiologists to applying stenting more often. In turn, with better outcomes and that could reduce the amount of open heart surgery.
We are looking forward to upcoming human trials in Canada and to completing our application to the FDA.
The team at Advanced Bifurcation Systems is really excited about recent development there. We recently had some great investor activity, were features in several online articles and a couple of very popular social posts, and chief medical officer and co-founder Mehran Khorsand presented our platform to great responses at the European Bifurcation Club meeting in Portugal.
This Huffington Post article got a lot of attention and a World News article have gotten some response too. I know it is just the beginning of lot of attention for our team. We are looking forward to sharing a lot of great company updates in the near future.
Event Sponsors of the European Bifurcation Club 2017
Advanced Bifurcation Systems is very proud to announce the sponsorship of the European Bifurcation Club 2017 (EBC2017). The event will hold in detail the advancements in cardiovascular technologies.
Advanced Bifurcation Systems will hold a cocktail event on Friday, the 13th, at 19:45 in the evening. This will conclude the end of this informative day. The cocktail hour will be held in the BRAGANCA meeting room (level 2) at The Crowne Plaza Hotel.
Dr. Mehran J. Khorsandi, MD, Co-Founder, Chairman & Chief Medical Officer of Advanced Bifurcation Systems will be presenting on Saturday, the 14th, in the morning session.
European Bifurcation Club is known in the industry as a referred thinking envelopment in the remedy of coronary bifurcation lesions. This club also keeps in contact with the medical industry. Keeping up to date in new developements in concepts, devices and procedures.
One of the main parts of this club is to organize future meetings and events having to do with the bifurcation industry.
Advanced Bifurcation Systems have sponsored many events in the past. We are really looking forward to this event in Portugal.
This is the fourth EBC meeting. It will be held in Porto Portugal at the Casa Das Artes hotel. Event starts Friday, October 13th and Saturday the 14th. Starting at 12:30 Friday and 8am on Saturday. There will be coffee breaks throughout.
Many many amazing presentations will be held. With some very well known industry speakers. The hotel recommended with special rates is the Crown Plaza Porto. The accommodations are rated very high and look very welcoming.
The venue Casa Das Artes, translates to the House of Arts. A beautiful space inside and out. With welcoming rooms for the presentations.
Join us for this amazing event. Please make sure you reserve your spot today and join us in this beautiful setting.
Building a startup can arguably be one of the most difficult challenges in business. So it is immensely gratifying and invigorating when you start to build momentum and see everyone’s hard work paying off big.
We have so many great things happen right now at ABS that it is hard to know where to start. But from media coverage to investor interest to the announcement of human trials in Canada, the team at Advanced Bifurcation Systems is enjoying seeing so much progress on so many fronts.
We are also sponsoring a cocktail party the first night of the meeting. The EBC meeting is a meeting of some of the top minds in the field and it will give our team a chance to show off the hard work and our innovative solution.